CSIMarket
 
Lensar Inc   (LNSR)
Other Ticker:  
 
 
Price: $6.8700 $1.01 17.235%
Day's High: $7.71 Week Perf: 27.7 %
Day's Low: $ 6.40 30 Day Perf: 44.94 %
Volume (M): 86 52 Wk High: $ 7.71
Volume (M$): $ 589 52 Wk Avg: $4.09
Open: $6.40 52 Wk Low: $1.92



 Market Capitalization (Millions $) 79
 Shares Outstanding (Millions) 11
 Employees -
 Revenues (TTM) (Millions $) 45
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -17
 Capital Exp. (TTM) (Millions $) 0

Lensar Inc
Lensar Inc. is a medical technology company that specializes in developing and manufacturing advanced laser systems for cataract surgery and other ophthalmic procedures. The company's flagship product is the Lensar Laser System, which integrates precise imaging and measurement technologies with femtosecond laser technology to improve the precision and outcomes of cataract surgeries. The Lensar Laser System offers surgeons improved control and accuracy during procedures, leading to faster recovery times and better patient outcomes. The company aims to innovate and advance ophthalmic care by developing cutting-edge technologies and providing reliable solutions for eye surgeons globally.


   Company Address: 2800 Discovery Drive Orlando 32826 FL
   Company Phone Number: 536-7271   Stock Exchange / Ticker: NASDAQ LNSR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX        3.9% 
ISRG        3.54% 
MDT   -2.16%    
SYK        0.73% 
ABT   -2.78%    
HOLX   -3.69%    
• View Complete Report
   



Shares

LENSAR Positions Itself for Growth: Grants Stock Options Amid One Million Milestone in Cataract Procedures,

Published Fri, Nov 1 2024 10:32 PM UTC

LENSAR, Inc. Grants Stock Options to New Hires Amid Celebratory Milestone in Cataract Surgery InnovationsOn November 1, 2024, LENSAR, Inc. (NASDAQ: LNSR), a prominent player in the field of ophthalmic laser technology, announced a notable step in its growth strategy by granting stock options to two newly-hired non-executive employees. This decision, made by the majority of i...

Product Service News

LENSAR Celebrates Milestone One Million Cataract Procedures Completed with Advanced Laser Technology

Published Tue, Oct 8 2024 12:01 PM UTC

In a remarkable achievement for both LENSAR, Inc. and the field of ophthalmology, the medical technology company announced recently that it has surpassed a significant milestone: the completion of one million cataract procedures utilizing its state-of-the-art LENSAR Cataract Laser System. This achievement is not just a statistic, but a reflection of the company's commitment ...

Management Announcement

LENSAR?s Strategic Moves Amid Financial Headwinds: A Focus on Innovation and Growth in Cataract Treatment

Published Tue, Oct 1 2024 10:26 PM UTC

Article Outline:1. Introduction - Overview of LENSAR, Inc., a medical technology company specializing in cataract treatment. - Mention recent stock options inducement to key personnel and financial performance.2. Recent Developments - Inducement Grants: On October 1, 2024, LENSAR's board granted stock options for 875 shares to two non-executive employees. - Complianc...

Business Update

LENSARs Vision for Success Record Growth in Advanced Cataract Treatments,

Published Thu, Aug 8 2024 11:47 AM UTC

'LENSAR's Growth Trajectory: Strong Q2 Results Illuminate Bright Future for Cataract Treatments'''In an era where innovation is crucial to healthcare success, medical technology company LENSAR, Inc. (Nasdaq: LNSR) is making waves with its impressive second-quarter performance. The Orlando-based organization has once again demonstrated its commitment to improving cataract tre...

Business Update

LENSAR?s ALLY Adaptive Cataract Treatment System Receives EU MDR Certification, Setting a New Benchmark in Ophthalm...

Published Wed, Aug 7 2024 11:51 AM UTC

ORLANDO, Fla.??LENSAR, Inc. (Nasdaq: LNSR), a leading global medical technology company specializing in advanced laser solutions for treating cataracts, has proudly announced that its groundbreaking ALLY Adaptive Cataract Treatment System (ALLY or ALLY System) has been awarded certification under the European Union?s (EU) stringent Medical Device Regulation (MDR). This certi...







Lensar Inc's Segments
United States    60.77 % of total Revenue
South Korea    2.41 % of total Revenue
Europe    13.21 % of total Revenue
Asia Excluding South Korea    7.82 % of total Revenue
Other    0.35 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com